Amir Kalali

Amir H.
Kalali is the founder of Decentralized Trials & Research Alliance.
Current positions include Chairman at Cns Summit, Director at Tikvah Therapeutics, Inc., Director at Neuroscience Education Institute, Independent Director at Atai Beckley, Inc. since 2021, Vice President-Medical & Scientific Services at Quintiles, Inc. (California), Professor at the University of California San Diego, and Executive Secretary at the International Society for CNS Drug Development.
Former roles include Director at Cypress Bioscience, Inc. from 2004 to 2011, Director at Dthera Sciences from 2018 to 2020, Global Head-Neuroscience Center Excellence at IQVIA, Inc. from 1997 to 2017, and Member-Supervisory Board at Atai Beckley NV.
Education includes a doctorate from the University of London.